Surgery Partners, Inc. (SGRY)
USD 20.31
(0.54%)
USD 20.31
(0.54%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.03 Billion USD | -28.15% |
| 2022 | 2.83 Billion USD | -11.38% |
| 2021 | 3.19 Billion USD | 3.26% |
| 2020 | 3.09 Billion USD | 10.17% |
| 2019 | 2.8 Billion USD | 15.99% |
| 2018 | 2.42 Billion USD | 13.62% |
| 2017 | 2.13 Billion USD | 45.06% |
| 2016 | 1.46 Billion USD | 14.19% |
| 2015 | 1.28 Billion USD | -7.63% |
| 2014 | 1.39 Billion USD | 232.68% |
| 2013 | 418.55 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.11 Billion USD | 3.82% |
| 2024 Q2 | 2.32 Billion USD | 10.76% |
| 2023 Q2 | 2.5 Billion USD | -10.53% |
| 2023 Q1 | 2.79 Billion USD | -1.08% |
| 2023 Q3 | 2.88 Billion USD | 15.02% |
| 2023 FY | 2.03 Billion USD | -28.15% |
| 2023 Q4 | 2.03 Billion USD | -29.42% |
| 2022 Q4 | 2.83 Billion USD | -16.07% |
| 2022 FY | 2.83 Billion USD | -11.38% |
| 2022 Q1 | 3.29 Billion USD | 3.23% |
| 2022 Q2 | 3.29 Billion USD | -0.18% |
| 2022 Q3 | 3.37 Billion USD | 2.47% |
| 2021 Q2 | 3.09 Billion USD | 0.39% |
| 2021 Q1 | 3.08 Billion USD | -0.27% |
| 2021 FY | 3.19 Billion USD | 3.26% |
| 2021 Q4 | 3.19 Billion USD | 2.89% |
| 2021 Q3 | 3.1 Billion USD | 0.24% |
| 2020 FY | 3.09 Billion USD | 10.17% |
| 2020 Q3 | 3.06 Billion USD | 5.0% |
| 2020 Q4 | 3.09 Billion USD | 0.84% |
| 2020 Q2 | 2.92 Billion USD | 0.54% |
| 2020 Q1 | 2.9 Billion USD | 3.48% |
| 2019 Q4 | 2.8 Billion USD | 4.6% |
| 2019 FY | 2.8 Billion USD | 15.99% |
| 2019 Q3 | 2.68 Billion USD | 1.2% |
| 2019 Q2 | 2.65 Billion USD | 0.46% |
| 2019 Q1 | 2.64 Billion USD | 9.07% |
| 2018 Q4 | 2.42 Billion USD | 7.27% |
| 2018 FY | 2.42 Billion USD | 13.62% |
| 2018 Q1 | 2.12 Billion USD | -0.38% |
| 2018 Q2 | 2.25 Billion USD | 6.16% |
| 2018 Q3 | 2.25 Billion USD | 0.15% |
| 2017 Q3 | 2.24 Billion USD | 24.93% |
| 2017 Q4 | 2.13 Billion USD | -5.0% |
| 2017 FY | 2.13 Billion USD | 45.06% |
| 2017 Q1 | 1.44 Billion USD | -1.28% |
| 2017 Q2 | 1.79 Billion USD | 23.82% |
| 2016 Q3 | 1.41 Billion USD | 2.29% |
| 2016 FY | 1.46 Billion USD | 14.19% |
| 2016 Q4 | 1.46 Billion USD | 3.98% |
| 2016 Q2 | 1.38 Billion USD | -0.24% |
| 2016 Q1 | 1.38 Billion USD | 7.62% |
| 2015 Q4 | 1.28 Billion USD | -9.88% |
| 2015 Q2 | 1.38 Billion USD | 3.86% |
| 2015 FY | 1.28 Billion USD | -7.63% |
| 2015 Q3 | 1.42 Billion USD | 2.72% |
| 2015 Q1 | 1.33 Billion USD | -3.92% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 1.39 Billion USD | 232.68% |
| 2014 Q4 | 1.39 Billion USD | 0.0% |
| 2013 FY | 418.55 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | -51.473% |
| Addus HomeCare Corporation | 124.13 Million USD | -1538.256% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -2825.917% |
| Amedisys, Inc. | 346.76 Million USD | -486.454% |
| American Oncology Network, Inc. | 120.44 Million USD | -1588.42% |
| Astrana Health, Inc. | 296.26 Million USD | -586.422% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | -59.33% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -1807.156% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -21809.13% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -76265.002% |
| COMPASS Pathways plc | 28.75 Million USD | -6971.67% |
| DocGo Inc. | 15.16 Million USD | -13312.55% |
| The Ensign Group, Inc. | 1.78 Billion USD | -13.938% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -18000.579% |
| InnovAge Holding Corp. | 100.49 Million USD | -1923.563% |
| Assure Holdings Corp. | 505 Thousand USD | -402593.069% |
| The Joint Corp. | 2 Million USD | -101580.0% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -625.547% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -533038.982% |
| ModivCare Inc. | 983.75 Million USD | -106.718% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -1709109.188% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -115536.453% |
| Option Care Health, Inc. | 1.05 Billion USD | -92.457% |
| P3 Health Partners Inc. | 108.31 Million USD | -1777.418% |
| P3 Health Partners Inc. | 108.31 Million USD | -1777.418% |
| The Pennant Group, Inc. | 312.51 Million USD | -550.731% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -2242.156% |
| The Oncology Institute, Inc. | 86.82 Million USD | -2242.156% |